{{Rsnum
|rsid=6673324
|Gene=LEPR
|Chromosome=1
|position=65565380
|Orientation=plus
|GMAF=0.3985
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=LEPR
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 29.2 | 53.1 | 17.7
| HCB | 81.8 | 18.2 | 0.0
| JPT | 75.2 | 23.9 | 0.9
| YRI | 29.9 | 47.6 | 22.4
| ASW | 21.4 | 58.9 | 19.6
| CHB | 81.8 | 18.2 | 0.0
| CHD | 80.7 | 19.3 | 0.0
| GIH | 18.0 | 52.0 | 30.0
| LWK | 20.0 | 46.4 | 33.6
| MEX | 17.2 | 50.0 | 32.8
| MKK | 16.8 | 52.9 | 30.3
| TSI | 22.5 | 46.1 | 31.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=20032477
|Title=Leptin receptor polymorphisms interact with polyunsaturated fatty acids to augment risk of insulin resistance and metabolic syndrome in adults
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}